NEUROCRINE BIOSCIENCES INC (NBIX)
Clinical trial NCT07187375 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 6 → 7 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07187375 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 6 → 7 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT02927509 updates: 1. start date: 2014-05-01 → 2016-02-01 2. completion date: not set → 2017-12-31 3. primary completion date: 2016-09-01 → 2017-12-31
Clinical trial NCT06894277: primary completion date: 2026-06-08 → 2026-08-08.
Clinical trial NCT07603401: status: TEMPORARILY_NOT_AVAILABLE → AVAILABLE.
Clinical trial NCT02927535 updates: 1. start date: 2015-01-01 → 2016-01-15 2. completion date: not set → 2017-12-31 3. primary completion date: 2016-09-01 → 2017-12-31
Clinical trial NCT06597734 updates: 1. completion date: 2029-08-31 → 2026-06-11 2. primary completion date: 2027-08-31 → 2026-06-11
Clinical trial NCT06052631: start date: 2026-06-18 → 2026-06-21.
Clinical trial NCT06317220: primary completion date: 2025-12-01 → 2026-02-17.
Clinical trial NCT06832618 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 240 → 159 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05159388 updates: 1. status: COMPLETED → TERMINATED 2. completion date: 2025-04-08 → 2025-04-01 3. primary completion date: 2025-04-08 → 2025-04-01 4. enrollment: 45 → 46 participants